Literature DB >> 20134302

ACOG Committee Opinion No. 451: Von Willebrand disease in women.

.   

Abstract

Approximately 3 million women in the United States have inherited bleeding disorders. The prevalence of bleeding disorders is particularly high among women with menorrhagia. Von Willebrand disease is the most common inherited bleeding disorder. Once a diagnosis is made, collaboration with a hematologist is helpful for long-term management. Women with von Willebrand disease may be at increased risk for gynecologic and obstetric complications. Many treatments are available for the control of menorrhagia in women with von Willebrand disease, but the first-line therapy remains combined hormonal contraception.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20134302     DOI: 10.1097/AOG.0b013e3181c6f975

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

Review 1.  Abnormal Uterine Bleeding in Young Women with Blood Disorders.

Authors:  Kathryn E Dickerson; Neethu M Menon; Ayesha Zia
Journal:  Pediatr Clin North Am       Date:  2018-06       Impact factor: 3.278

Review 2.  Delineating the Hemostaseome as an aid to individualize the analysis of the hereditary basis of thrombotic and bleeding disorders.

Authors:  Kim Fechtel; Marika L Osterbur; Hildegard Kehrer-Sawatzki; Peter D Stenson; David N Cooper
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

3.  Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologists.

Authors:  Vanessa R Byams; Britta L Anderson; Althea M Grant; Hani Atrash; Jay Schulkin
Journal:  Am J Obstet Gynecol       Date:  2012-07-16       Impact factor: 8.661

4.  Levonorgestrel intrauterine system as a treatment option for severe menorrhagia in adolescent with type III von Willebrand disease.

Authors:  Carla Donato Silva; Fernanda Geraldes; Isabel Santos Silva
Journal:  BMJ Case Rep       Date:  2013-04-30

Review 5.  von Willebrand disease.

Authors:  Paula D James; Anne C Goodeve
Journal:  Genet Med       Date:  2011-05       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.